Cresco Labs Inc. SEC filings CRLBF
Cresco Labs Inc. has 93 filings in SEC EDGAR's recent list, going back to Jan 13, 2021. Its latest annual report, Form 40-F, was filed on Mar 6, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 2, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 13, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | May 8, 2026 | Mar 31, 2026 |
| 40-F | Annual report (Canadian issuer) | Mar 6, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Feb 2, 2026 | Jan 30, 2026 |
| EFFECT | Filing | Dec 11, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 7, 2025 | Nov 7, 2025 |
| F-X | Filing | Oct 6, 2025 | — |
| F-10 | Filing | Oct 6, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 22, 2025 | Sep 22, 2025 |
| SC TO-I/A | Filing | Sep 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 17, 2025 | Sep 16, 2025 |
| SC TO-I | Filing | Aug 20, 2025 | — |
| SC TO-C | Filing | Aug 20, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 15, 2025 | Aug 15, 2025 |
| 6-K | Current report (foreign issuer) | Aug 7, 2025 | Aug 7, 2025 |
| 6-K | Current report (foreign issuer) | Jun 13, 2025 | Jun 12, 2025 |
| 6-K | Current report (foreign issuer) | May 30, 2025 | May 30, 2025 |
| 40-F | Annual report (Canadian issuer) | Mar 14, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 12, 2025 | Mar 12, 2025 |
| 6-K | Current report (foreign issuer) | Nov 12, 2024 | Nov 8, 2024 |
| 6-K | Current report (foreign issuer) | Sep 30, 2024 | Sep 27, 2024 |
| 6-K | Current report (foreign issuer) | Sep 12, 2024 | Sep 12, 2024 |
| S-8 | Employee stock plan registration | Aug 9, 2024 | — |
| 6-K | Current report (foreign issuer) | Aug 9, 2024 | Aug 8, 2024 |
| 6-K | Current report (foreign issuer) | Jul 11, 2024 | Jul 10, 2024 |
| 6-K | Current report (foreign issuer) | Jun 10, 2024 | Jun 10, 2024 |
| 6-K | Current report (foreign issuer) | May 16, 2024 | May 15, 2024 |
| CB/A | Filing | May 8, 2024 | — |
| CB/A | Filing | Apr 12, 2024 | — |
| CB | Filing | Apr 10, 2024 | — |
| 40-F | Annual report (Canadian issuer) | Mar 18, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 13, 2024 | Mar 13, 2024 |
| 6-K | Current report (foreign issuer) | Feb 6, 2024 | Feb 6, 2024 |
| 6-K | Current report (foreign issuer) | Nov 16, 2023 | Sep 30, 2023 |
| F-X | Filing | Aug 17, 2023 | — |
| F-10 | Filing | Aug 17, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 17, 2023 | Aug 16, 2023 |
| 6-K | Current report (foreign issuer) | Jul 31, 2023 | Jul 31, 2023 |
| 6-K | Current report (foreign issuer) | Jun 30, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | May 26, 2023 | May 25, 2023 |
| 40-F | Annual report (Canadian issuer) | Mar 22, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 16, 2023 | Mar 16, 2023 |
| 6-K | Current report (foreign issuer) | Nov 17, 2022 | Nov 17, 2022 |
| 6-K | Current report (foreign issuer) | Oct 26, 2022 | Oct 25, 2022 |
| 6-K | Current report (foreign issuer) | Aug 23, 2022 | Aug 23, 2022 |
| 6-K | Current report (foreign issuer) | Jun 21, 2022 | Jun 21, 2022 |
| 6-K | Current report (foreign issuer) | Jun 16, 2022 | Jun 6, 2022 |
| 6-K | Current report (foreign issuer) | May 19, 2022 | May 19, 2022 |
| 40-F | Annual report (Canadian issuer) | Apr 5, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Apr 4, 2022 | Mar 31, 2022 |
| 6-K | Current report (foreign issuer) | Apr 1, 2022 | Apr 1, 2022 |
| D | Filing | Dec 21, 2021 | — |
| 6-K | Current report (foreign issuer) | Nov 22, 2021 | Nov 19, 2021 |
| 6-K | Current report (foreign issuer) | Nov 15, 2021 | Nov 12, 2021 |
| 6-K | Current report (foreign issuer) | Sep 27, 2021 | Sep 27, 2021 |
| 6-K | Current report (foreign issuer) | Sep 8, 2021 | Sep 7, 2021 |
| 6-K | Current report (foreign issuer) | Aug 27, 2021 | Aug 26, 2021 |
| 6-K | Current report (foreign issuer) | Jun 11, 2021 | Jun 10, 2021 |
| 6-K | Current report (foreign issuer) | Jun 1, 2021 | Jun 1, 2021 |
| 6-K | Current report (foreign issuer) | May 28, 2021 | May 28, 2021 |
| 6-K | Current report (foreign issuer) | May 21, 2021 | May 21, 2021 |
| 6-K | Current report (foreign issuer) | May 3, 2021 | Apr 30, 2021 |
| 40-F/A | Amended annual report (Canadian issuer) | Apr 29, 2021 | Dec 31, 2020 |
| F-10/A | Filing | Apr 23, 2021 | — |
| 40-F | Annual report (Canadian issuer) | Mar 30, 2021 | Dec 31, 2020 |
| 6-K | Current report (foreign issuer) | Mar 29, 2021 | Mar 29, 2021 |
| F-10 | Filing | Mar 1, 2021 | — |
| S-8 | Employee stock plan registration | Mar 1, 2021 | — |
| 6-K | Current report (foreign issuer) | Feb 24, 2021 | Feb 23, 2021 |
| SEC STAFF ACTION | Filing | Jan 27, 2021 | — |
| CORRESP | Letter to the SEC | Jan 25, 2021 | — |
| F-X | Filing | Jan 14, 2021 | — |
| 40FR12G | Filing | Jan 13, 2021 | — |
Showing 76 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CRLBF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Chicago, IL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1832928
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.